agree with the analysis entirely and there will be plenty of...

agree with the analysis entirely and there will be plenty of upcoming conferences with a research focus that will make sense for being the recipients of a rigorous update on the trial progress.

for mine, the real upside I want to see from the conference is being able to get a few more institutional investors onboard and try and tidy up our shareholder register. I think a big part of our volatility comes from the exceptionally high percentage of retail holders and hence being subject a little more to the seasonal winds of sentiment.
if in the next few months we can get another 15-20% of the register into some larger funds to tamp down our volatility, enable a stronger justification for nasdaq listing and help build a stronger share price prior to some commercialisation event. I genuinely feel a market cap around 1.5-2B USD is where we want to get to prior to the business end of discussions around out licensing our first product.

Hoping Leslie, Paul, Monil and team can get a few 5% holders. At current market cap - that’s around $usd 30m per 5% slice of the pie. Maybe $35M if you want to buy in a hurry on market

happy Sunday all,

cheers - YS